Koyfin Home > Directory > Health Care > Kindred Biosciences > Total Debt / Equity

Kindred Biosciences Total Debt / Equity Chart (KIN)

Kindred Biosciences annual/quarterly Total Debt / Equity from 2019 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Kindred Biosciences Total Debt / Equity for the quarter ending June 06, 2020 was $26m a 17.26% increase of 5m year over year
  • Kindred Biosciences Total Debt / Equity for the last 12 months ending June 06, 2020 was $26m a 17.26% increase of 5m year over year
Other Ratios Metrics:
  • Kindred Biosciences Other Liabilities for the quarter ending December 12, 2018 was $0m a -18.09% decrease of 0m year over year
View Chart On Koyfin

Quarterly KIN Total Debt / Equity Data

06/2020$26m
03/2020$37m
12/2019$27m
09/2019$22m
06/2019$2m
03/2019$1m

Annual KIN Total Debt / Equity Data

2019$27m